Refine by
Conductivity Analysis Articles & Analysis: Older
31 news found
A key distinguishing factor that sets Creative Enzymes apart in enzyme discovery is its state-of-the-art laboratories equipped with advanced technology. This enables the company to conduct comprehensive research and analysis for the efficient identification and characterization of novel enzymes. ...
We are delighted to welcome Roczen to the community of healthcare organisations leveraging Vantage Software! We look forward to working together and helping them deliver exceptional care and support to those living with chronic conditions. Book a Free Demo ...
CD Genomics' Degradome Sequencing service empowers researchers to conduct comprehensive analyses of RNA degradation patterns, providing an intricate portrait of the ever-evolving RNA landscape within cells and tissues. ...
Analytical Testing Services for Microspheres & MicroneedlesHaving abundant experience in the large-scale production of microspheres and microneedles, CD Formulation’s biopharmaceutical laboratory and amplification platform is also capable of conducting analytical testing services for customers worldwide to ensure the quality of microspheres and microneedles. ...
Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic ...
KCAS Bioanalytical & Biomarker Services is conducting the pharmacokinetic (PK) analysis. “As Cingulate proceeds with its mission to bring next-generation medications to patients where standard-of-care treatments result in suboptimal outcomes, we are pleased to have completed this trial advancing our understanding of the absorption and bioavailability ...
Creative Biogene provides comprehensive mitochondrial gene expression solutions, which aim to conduct in-depth analyses of mitochondrial disorders from a holistic perspective. ...
Additionally, revenue growth was driven by United States Department of Defense (DoD) orders as well as third-party companies contracting with Daxor to conduct blood volume analysis on their products. The Company also reported its successful execution of a Department of Defense contract to build a next-generation portable rapid blood volume analyzer for both ...
Together with state-of-the-art analytical instruments, the company is capable of conducting analytical process development and validation services for drug formulation projects. ...
(NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the publication of a scientific paper titled “Exodus: Sequencing-based Pipeline for Quantification of Pooled Variants” in the journal, Bioinformatics. The research ...
ByBiomX
Post hoc analyses conducted in patient populations at greater risk of progression to severe disease or death suggests that SNG001 may have an important clinical effect on top of standard of care Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today ...
“FFRangio has been in use in our cath lab since 2016 and we have taken part in several studies demonstrating its excellent diagnostic performance compared to the gold standard wire-based FFR, culminating in the pivotal FAST-FFR trial and our leading role in conducting a pooled analysis that compared FFRangio to wire-based FFR. Based on the results of these ...
Efficacy A total of 623 patients were randomised to receive SNG001 (n=309) or placebo (n=314) in addition to standard of care (SOC). The primary analysis was conducted in the intention-to-treat population (ITT; all randomised patients). ...
--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its iDose® TR sustained-release travoprost implant continued to provide sustained substantial reductions in intraocular pressure (IOP) in a 36-month ...
For artificially designed protein drugs with specific biological activities and curative effects, such as engineered antibodies, antibody-drug conjugates, antibody-based fusion proteins, etc., it is necessary to conduct careful analysis and testing of factors such as modification or processing efficiency, modification specificity and accuracy, and stability after ...
BioGX’s SARS-CoV-2 surveillance program includes exhaustive in-silico analysis and experimental testing by BioGX scientists using RNA sequences containing the mutations present within the emerging SARS-CoV-2 variants. The analysis conducted by BioGX confirmed the BioGX portfolio of COVID-19 tests maintain detection coverage for all variants ...
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...
Comparing the differential changes in the expression of a large number of proteins in different normal and tumor samples or samples under different treatment conditions. 2. Large-scale analysis of post-translational modification sites in proteins and the changes in protein modification levels under different conditions. 3. ...
IPA, the full name of which is Ingenuity Pathway Analysis, is an all-in-one and web-based software application. Unlike other search and analysis software, IPA is supported by the Ingenuity Knowledge Base with highly structured and detailed biological and chemical discoveries. ...
Two primary outcome measures were assessed: cost and utility. In the base-case analysis, both health and societal system costs were evaluated. “In a robust cost-utility analysis, i-FACTOR reduced costs within the first year compared to the control group (autograft) in the ACDF IDE trial population. ...